168 related articles for article (PubMed ID: 7820072)
1. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4.
Wolfman C; Abó V; Calvo D; Medina J; Dajas F; Silveira R
Neurochem Int; 1994 Oct; 25(4):395-400. PubMed ID: 7820072
[TBL] [Abstract][Full Text] [Related]
2. Effects of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on alpha2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain.
Prieto M; Giralt MT
Pharmacol Toxicol; 2001 Mar; 88(3):152-8. PubMed ID: 11245411
[TBL] [Abstract][Full Text] [Related]
3. DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.
Jonsson G; Hallman H; Ponzio F; Ross S
Eur J Pharmacol; 1981 Jun; 72(2-3):173-88. PubMed ID: 6265244
[TBL] [Abstract][Full Text] [Related]
4. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.
Jonsson G; Hallman H; Sundström E
Neuroscience; 1982; 7(11):2895-907. PubMed ID: 7155358
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
Hallman H; Jonsson G
Eur J Pharmacol; 1984 Aug; 103(3-4):269-78. PubMed ID: 6237924
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat.
Szot P; Miguelez C; White SS; Franklin A; Sikkema C; Wilkinson CW; Ugedo L; Raskind MA
Neuroscience; 2010 Mar; 166(1):279-91. PubMed ID: 20045445
[TBL] [Abstract][Full Text] [Related]
7. DSP4, a selective neurotoxin for the locus coeruleus noradrenergic system. A review of its mode of action.
Ross SB; Stenfors C
Neurotox Res; 2015 Jan; 27(1):15-30. PubMed ID: 24964753
[TBL] [Abstract][Full Text] [Related]
8. Effects of the noradrenaline neurotoxin N-2-chloroethyl-N-ethyl-2-bromo-benzylamine hydrochloride (DSP4) on the blood-brain barrier. An experimental study in the mouse using protein tracer and density determination techniques.
Tengvar C; Pettersson CA; Mohammed AK; Olsson Y
Acta Neuropathol; 1989; 78(1):28-34. PubMed ID: 2735187
[TBL] [Abstract][Full Text] [Related]
9. DSP4-induced noradrenergic lesions increase beta-adrenergic receptors and hippocampal electrophysiological responsiveness.
Zahniser NR; Weiner GR; Worth T; Philpott K; Yasuda RP; Jonsson G; Dunwiddie TV
Pharmacol Biochem Behav; 1986 May; 24(5):1397-402. PubMed ID: 3014567
[TBL] [Abstract][Full Text] [Related]
10. DSP4-induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion.
Archer T; Ogren SO; Johansson G; Ross SB
Psychopharmacology (Berl); 1982; 76(4):303-9. PubMed ID: 6812102
[TBL] [Abstract][Full Text] [Related]
11. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
Harro J; Jossan SS; Oreland L
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
[TBL] [Abstract][Full Text] [Related]
12. The neurotoxic compound N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) depletes endogenous norepinephrine and enhances release of [3H]norepinephrine from rat cortical slices.
Landa ME; Rubio MC; Jaim-Etcheverry G
J Pharmacol Exp Ther; 1984 Oct; 231(1):131-6. PubMed ID: 6491970
[TBL] [Abstract][Full Text] [Related]
13. Noradrenaline and dopamine interaction in rat brain during development.
Ponzio F; Hallman H; Jonsson G
Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787
[TBL] [Abstract][Full Text] [Related]
14. Effect of selective noradrenergic denervation on noradrenaline content and [3H]dopamine release in rat nucleus accumbens slices.
Russell VA; Lamm MC; Allin R; de Villiers AS; Searson A; Taljaard JJ
Neurochem Res; 1989 Feb; 14(2):169-72. PubMed ID: 2725817
[TBL] [Abstract][Full Text] [Related]
15. [N-2-chloroethyl-N-ethyl-2-bromobenzylamine (DSP4) increases the liberation of 3H-noradrenaline produced by depolarization of the nerve ending].
Landa ME; Rubio MC; Jaim-Etcheverry G
Acta Physiol Pharmacol Latinoam; 1988; 38(2):167-80. PubMed ID: 2847491
[TBL] [Abstract][Full Text] [Related]
16. Alpha2-adrenoceptor modulation of cortical acetylcholine release in vivo.
Tellez S; Colpaert F; Marien M
Neuroscience; 1999; 89(4):1041-50. PubMed ID: 10362293
[TBL] [Abstract][Full Text] [Related]
17. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
Fritschy JM; Grzanna R
Prog Brain Res; 1991; 88():257-68. PubMed ID: 1726027
[TBL] [Abstract][Full Text] [Related]
18. Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease.
Heneka MT; Galea E; Gavriluyk V; Dumitrescu-Ozimek L; Daeschner J; O'Banion MK; Weinberg G; Klockgether T; Feinstein DL
J Neurosci; 2002 Apr; 22(7):2434-42. PubMed ID: 11923407
[TBL] [Abstract][Full Text] [Related]
19. N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) impairs neurotransmission in the vas deferens of the rat.
Landa ME; Fiszman ML
Gen Pharmacol; 1993 May; 24(3):733-8. PubMed ID: 8396060
[TBL] [Abstract][Full Text] [Related]
20. A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat.
Archer T; Jonsson G; Ross SB
Br J Pharmacol; 1984 May; 82(1):249-57. PubMed ID: 6733355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
